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rostaglandin and Echocardiography
hat’s what started this whole journey. Before the end of the 1970s, most
neonates with critical congenital heart disease (CHD) did not survive if their
pulmonary or systemic blood flow was dependent on a patent ductus arte-
iosus. Even in the rare neonate who was lucky enough to have spontaneous patency
f the ductus, making a complete diagnosis to plan cardiac surgery required
atheterization; 30 years ago cardiac catheterization was associated with significant
orbidity, especially in a fragile neonate. It’s no wonder surgical mortality was so
igh in those days. Even though the technical aspects of cardiac surgery could be
pplied to small babies, the status of the infant entering the operating room was
enuous, and the infant not infrequently had an incomplete diagnosis.
Enter bedside noninvasive diagnostic capabilities and the availability of medical
upport to stabilize the infant. Mechanical ventilation was being applied to smaller
nd smaller infants, hemodynamic monitoring was improving, and the new subspe-
ialty of cardiac intensive care allowed for increasingly stable babies to survive
alliative and reparative procedures. Improvements in surgical technique and car-
iopulmonary bypass followed soon thereafter. Intraoperative echocardiography
ncreased the likelihood of leaving the operating room with a better understanding
f the physiology of the neonate and status of the repair.
For those of us in the practice of pediatric cardiology, this was an exciting time
ndeed. Survival, even for infants with the most complex lesions, was now expected.
ardiologists and intensivists painted a very different prognosis for families than we
ad even 10 years earlier. However, with these successes came new realizations. As
e began to observe these outpatients in larger numbers, we recognized that there
as an unexpectedly high prevalence of psychosocial, neurologic, developmental,
nd psychiatric disabilities in the survivors as they entered and proceeded through
ormal education. Gross and fine motor delays, learning disabilities, inattention,
yperactivity, internalizing and externalizing behaviors, and speech and language
ifficulties have all been reported with disturbingly high frequency, approaching
0% to 50% in some subgroups.1 The neurodevelopmental burden of disease is, for
any children and their families, much more significant than the daily impact of
heir CHD.E1 (See E-References on line.) Many families of teenagers with complex
HD and significant learning or behavioral problems openly ask me why they were
ot informed of these potential problems when their children were born. It is of little
olace that I tell them that when their child was born in the late 1980s and early
990s, there were simply not enough school-age survivors to know the true impact
f CHD and its management on longer term quality of life. Fortunately, children and
heir parents began to participate in longitudinal clinical research efforts so that we
ight gain improved understanding of the types and frequency of neurodevelop-
ental dysfunction and begin to understand the mechanism(s) of injury.















































































































n this issue, the investigators at Children’s Hospital Boston
resent another in a series of important investigations aimed
t improving our understanding of the mechanisms of cen-
ral nervous system injury in the operating room and pro-
osing changes in management to improve the longer term
utlook for our current patients.2,3 At the outset, Newburger
cardiology), Jonas (cardiac surgery), Bellinger (psychol-
gy), Wypij (biostatistics), and their many colleagues un-
erstood the value in the multidisciplinary design of clinical
nvestigations. I was fortunate as a junior physician to be
entored by that group. Partnership extended from study
esign through implementation in the intensive care unit,
etting “buy-in” from colleagues in medicine, surgery, an-
sthesia, and nursing, and most importantly, the families of
ur patients. We believed then, as now, that clinical inves-
igation of long-term outcomes was a moral imperative and
ll needed to participate as partners in the challenge, from
any disciplines both inside and outside of pediatric cardi-
logy and surgery. Whereas getting many investigators (fre-
uently seasoned investigators with long research track
ecords) to agree on the important questions, the patient
opulation to study, the financial realities of clinical studies,
nd even the order of authors on manuscripts was “chal-
enging,” equipoise was perhaps the hardest of all hurdles to
vercome. In our field, it is natural to “know” (or be
xpected to know) the “correct” approach to a procedure,
he “right” diagnosis: the “truth.” How can a surgeon with
o much on the line be expected to “flip a coin” to decide
hat bypass strategy to use, what surgical technique to use?
ow could we convince parents of critically ill neonates to
ign a consent form allowing us to be—by design—random
n our decision making?E2 How could we convince our
olleagues who referred patients to us to allow their patients
o enter a clinical trial? These were difficult problems in
heory, but the leadership in the cardiovascular program
rovided by Dr Aldo Castañeda and Dr James Lock con-
inued to foster an approach that this was clearly the best
ay in which the field could move forward and improve
esults for the next generation. Multidisciplinary study
roups were encouraged and indeed became the model of
linical investigation of long-term outcomes for our
atients.
The knowledge gained from the randomized trials in
oston have included investigations of the use and du-
ation of deep hypothermic circulatory arrest,4,5,E6-E11 pH
anagement,6,E12 and, in the current issue, follow-up and
urther analysis on the effect of hematocrit management
uring cardiopulmonary bypass.2,3,E13 Much has been
earned from these trials that has affected our current ap-
roaches to cardiopulmonary bypass and perioperative man-
gement. In addition to the lessons learned from the impor-
ant trials in Boston, a subtle “culture change” has occurred i
The Journal of Thoracicn our field. New changes in technique are more frequently
ubjected to critical review and implemented as clinical
rials rather than immediately adopted as “better” or
proven.” Practice change by anecdote, seniority, or by
omparing new techniques to historical controls is no longer
 viable, acceptable strategy.E14 Additional randomized
linical trials of intraoperative and perioperative manage-
ent have recently been publishedE15,E16 and are currently
nderway, including multicenter trials supported by the
ediatric Heart Network (www.pediatricheartnetwork.org/
urrentstudies.asp, accessed 2007).
rospective and Evidence-based Studies
n addition to the randomized studies in Boston, a number of
ohorts are currently being evaluated prospectively with
rotocol-driven follow-up to learn more about the impact of
actors outside the operating room that affect long-term neu-
odevelopmental outcomes. Large cohorts of patients with
eterogeneous CHD are currently being prospectively fol-
owed up at The Children’s Hospital of Philadelphia7,E17-E20 as
ell as at Montreal Children’s Hospital8,E21-E28 and the Uni-
ersity Hospital in Aachen, Germany.9,E29-35 Additional pro-
pective and cross-sectional reports are increasingly prevalent
n the literature.E36-E42 All of the current evidence points to the
act that modifications of technique in the operating room,
lthough important, contribute but a small fraction to the
ariability of longer term outcomes in the decades that
ollow neonatal cardiac intervention. Instead, nonmodifiable
actors such as gestational age, birth weight, genetic syn-
romes and polymorphisms, maternal education, and socio-
conomic status have been consistently and significantly
mplicated as major contributors to long-term outcome.E43
herefore, prospective studies must continue to define the
mpact of modifiable risk factors: how we operate, when we
perate, and importantly, how we manage the patient in the
ntensive care unit. During a typical hospitalization for
eonatal heart surgery, only a small fraction of the total
ength of stay is spent in the operating room, where a
isproportionate (though very important) amount of clinical
nvestigation has taken place. Resources and clinical inves-
igations need also to study management patterns in the
ntensive care unit. Changes in management must be ac-
ompanied by investigation into their short- and long-term
mpact to establish an evidence base to design future pro-
pective follow-up studies and randomized treatment clini-
al trials. Just a few examples of practice patterns that have not
een adequately studied for their impact on longer term neu-
odevelopment include timing of surgery in critical lesions,
routine” delayed sternal closure,E44-E47 management of
yperglycemia,E48,E49 temperature control,E50-E52 nutrition,E53
nd the impact of mechanical ventilation/hyperventilationE54
n longer term outcomes. Some are likely to be important, and
t is time to study factors in the intensive care unit as
























Ligorously as we have studied factors in the operating room.
e need to be more critical of our current strategies as
eing “right.” We should model our trials and clinical
nvestigations on the approach taken by the Boston group
or nearly 20 years, to have equipoise regarding our current
trategies, study them rigorously, in a multidisciplinary,
ulticenter, and importantly, long-term fashion. We may
nd that our practices and established techniques may be all
rong.
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